The Venous Center

Filter Your Results

 

News

 

Q3 Medical Financing Agreement to Support Product Development and Commercialization

March 15, 2017 -- Q3 Medical Devices Limited announced that it has entered into an €28.3-million investment agreement with Boill Holding Group of Shanghai, China. Th…

Double-Blind Study Compares Angioplasty to Sham to Treat CCSVI in MS

March 8, 2017 -- The University of British Columbia (UBC) announced findings from a study showing that venoplasty to open narrowed veins from the brain and spinal cord is…

2-Year ATTRACT Data: Anticoagulation Alone Best for Most DVT; PCDT Benefits Seen in Certain Iliofemoral Patients

March 6, 2017 -- The much-anticipated 2-year results from the ATTRACT study were presented by Suresh Vedantham, MD, FSIR, on behalf of the trial’s investigators, at the …

Bluegrass Vascular Forms Strategic Relationship With Merit Medical

March 6, 2017 -- Bluegrass Vascular Technologies announced a strategic relationship with Merit Medical Systems that will streamline European distribution of Bluegras…

What to Watch for in the ATTRACT Study Data Presentation

An interview with Principal Investigator Suresh Vedantham, MD.

FDA Clears BTG's Ekos Control Unit 4.0

February 27, 2017 -- BTG International announced US Food and Drug Administration 510(k) clearance for the company's Ekos Control Unit 4.0 to power the Ekos syste…

Combined Stent Placement Studied for Postthrombotic CTOs of the Iliofemoral Veins

January 18, 2017 -- Wang Ruihua, PhD, et al published findings from a study that evaluated the technical aspects and early clinical results of combined stent placement for the…

EMIT-AF/VTE Registry Initiated to Evaluate Daiichi Sankyo's Lixiana

December 13, 2016 -- Daiichi Sankyo Europe GmbH announced that the first patient has been enrolled in the EMIT-AF/VTE registry, which will collect real-world clinical dat…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.